Understanding drug targets: there’s no such thing as bad news. Drug Discovery Today, 23, 1925-1928.
How can small-to-medium pharma and biotech companies enhance the chances of running a successful drug project and maximise the return on a limited number of assets? Having a full appreciation of the safety risks associated with proposed drug targets is a crucial element in understanding the unwanted side-effects that might stop a project in its tracks. Having this information is necessary to complement knowledge about the probable efficacy of a future drug…
By Chloe Atkinson|2022-11-28T14:09:15+00:00June 17th, 2021|Comments Off on Understanding drug targets: there’s no such thing as bad news. Drug Discovery Today, 23, 1925-1928.